Detalhe da pesquisa
1.
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.
J Allergy Clin Immunol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878020
2.
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
Br J Haematol
; 202(5): 937-941, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287128
3.
COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood.
Front Immunol
; 14: 1211558, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465682
4.
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection.
Open Forum Infect Dis
; 10(5): ofad226, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37213426
5.
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment.
medRxiv
; 2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398319
6.
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.
Blood Cancer Discov
; 4(2): 106-117, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511813
7.
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers.
iScience
; 26(11): 108256, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965140